Pharma Pulse: FDA Launches AEMS and the Rise of Direct-to-Employer Drug Purchasing

In today’s Pharma Pulse, the FDA launched a unified monitoring system to enable real-time adverse event reporting, and direct-to-employer drug purchasing models are emerging as companies look to bypass traditional intermediaries.